Olivier Govaere
191 works · 11,600 citations · h-index 48
Top works
- NASH limits anti-tumour surveillance in immunotherapy-treated HCC
- From NASH to HCC: current concepts and future challenges
- Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease
- Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes
- Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma
- Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis
- Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆
- Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis
- Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis
- Keratin 19: a key role player in the invasion of human hepatocellular carcinomas
- Chemokine (C‐C motif) receptor 2–positive monocytes aggravate the early phase of acetaminophen‐induced acute liver injury
- Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?
- Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis
- Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease
- TGFβ inhibition restores a regenerative response in acute liver injury by suppressing paracrine senescence
- Chemokine Receptor CCR6-Dependent Accumulation of γδ T Cells in Injured Liver Restricts Hepatic Inflammation and Fibrosis
- Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching
- FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis
- An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)
- Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease